VP
PHVS icon

venBio Partners’s Pharvaris PHVS Stock Holding History

venBio Partners’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161M Buy
4,643,430
+4,126
+0.1% +$125K 30.92% 1
2026
Q1 		$131M Hold
4,639,304
– – 46.72% 1
2025
Q4 		$129M Hold
4,639,304
– – 59.53% 1
2025
Q3 		$116M Buy
4,639,304
+350,000
+8% +$7.76M 65.62% 1
2025
Q2 		$75.5M Hold
4,289,304
– – 65.78% 1
2025
Q1 		$67.3M Hold
4,289,304
– – 54.5% 1
2024
Q4 		$82.2M Hold
4,289,304
– – 48.17% 1
2024
Q3 		$79.4M Hold
4,289,304
– – 40.88% 1
2024
Q2 		$80.6M Hold
4,289,304
– – 34.83% 1
2024
Q1 		$99.1M Sell
4,289,304
-630,200
-13% -$16.7M 35.17% 2
2023
Q4 		$138M Buy
4,919,504
+654,832
+15% +$13.3M 20.68% 3
2023
Q3 		$89M Hold
4,264,672
– – 25.24% 2
2023
Q2 		$64.6M Buy
4,264,672
+1,986,097
+87% +$19.2M 23.37% 3
2023
Q1 		$18.4M Sell
2,278,575
-18,135
-0.8% -$160K 10.17% 4
2022
Q4 		$25.8M Hold
2,296,710
– – 8.01% 4
2022
Q3 		$17.6M Sell
2,296,710
-4,741
-0.2% -$74.1K 4.08% 6
2022
Q2 		$50.9M Sell
2,301,451
-1,859
-0.1% -$34.6K 14.48% 4
2022
Q1 		$41.8M Hold
2,303,310
– – 9.26% 4
2021
Q4 		$33.1M Hold
2,303,310
– – 5.97% 5
2021
Q3 		$40.8M Hold
2,303,310
– – 4.07% 4
2021
Q2 		$42.9M Hold
2,303,310
– – 5.06% 4
2021
Q1 		$64.4M Buy
+2,303,310
New +$72.5M 6.12% 4

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

venBio Partners's PHVS Position: Q2 2026 in Review

venBio Partners increased its Pharvaris (PHVS) stake by 0.09% in Q2 2026, buying an estimated $125K and bringing the position to 4,643,430 shares worth $161M. The position accounts for 30.92% of the portfolio, ranked #1.

venBio Partners first reported a position in PHVS in Q1 2021 and has held it in 22 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • venBio Partners held 4,643,430 shares of Pharvaris worth $161M as of Q2 2026.
  • venBio Partners bought 4,126 Pharvaris shares in Q2 2026, an estimated $125K.
  • Pharvaris made up 30.92% of venBio Partners's portfolio in Q2 2026, its #1 holding.
  • venBio Partners first reported a position in Pharvaris in Q1 2021 and has held it in 22 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on venBio Partners's 13F filing for Q2 2026, filed 14 Aug 2026.